Saturday, June 12th | 2 Tammuz 5781

Subscribe
February 5, 2015 11:55 am
0

Jewish 100, 2014: Ephrat Levy-Lahad – Innovation and Activism

avatar by Algemeiner Staff

Ephrat Levy-Lahad. Photo: Breast Cancer Research Foundation.

Ephrat Levy-Lahad

Medical researcher

All women of Ashkenazi origin should be screened for two breast-cancer predisposition genes from the age of 30, said Prof. Ephrat Levy-Lahad, the head of a leading research team at Shaare Zedek Medical Center. Levy-Lahad’s 2014 announcement, which received international attention, was a departure from the previous guideline of testing for the two BRCA genes only if a close blood relative contracted breast or ovarian cancer. The finding will likely change screening practices in Israel and in Jewish communities worldwide, ultimately saving lives.

Share this Story: Share On Facebook Share On Twitter

Let your voice be heard!

Join the Algemeiner

Algemeiner.com

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.